The cost of mass drug administration for trachoma in two counties of the Republic of South Sudan
Open Access
- 19 July 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 4 (7) , e0003242
Abstract
Community-wide distribution of azithromycin, otherwise known as mass drug administration (MDA), is a component of the World Health Organization-endorsed SAFE strategy for the elimination of trachoma as a public health problem. In the Republic of South Sudan, 2.9 million people are known to live in areas that are known to require interventions and warrant MDA. This study estimated the total costs and cost per person treated during MDA in two counties, Kapoeta North and Kapoeta East, in South Sudan. MDA was conducted in Kapoeta North and Kapoeta East counties from October 2020 to January 2021. Following training and community sensitization, a core team, consisting of a height measurer, a drug dispenser, and a data recorder, delivered the intervention. A detailed costing database was developed in Microsoft Excel. An ingredients approach was used to capture all financial and economic costs incurred from a payer perspective. Primary outcomes included the total cost of MDA in each county and the cost per person treated in each county. In Kapoeta North, 58,226 people were treated at a financial cost of $71,350 USD. This corresponds to a unit cost of $1.22 per person treated. The total economic cost of the intervention was $99,036, at a unit cost of $1.70 per person treated. In Kapoeta East, 156,092 people were treated at a total financial cost of $168,404. This corresponds to a unit cost of $1.08 per person treated. The total economic cost of the intervention was $243,205, at a unit cost of $1.56 per person treated. The study highlights the cost variation for MDA implementation across two counties of South Sudan. As the South Sudan trachoma program expands, this information will be valuable for program planning.Keywords
This publication has 10 references indexed in Scilit:
- Economic Evaluations of Mass Drug Administration: The Importance of Economies of Scale and ScopeClinical Infectious Diseases, 2017
- Burden of trachoma in five counties of Eastern Equatoria state, South Sudan: Results from population-based surveysPLOS Neglected Tropical Diseases, 2017
- Cost effectiveness of strategies to combat vision and hearing loss in sub-Saharan Africa and South East Asia: mathematical modelling studyBMJ, 2012
- The Cost of Antibiotic Mass Drug Administration for Trachoma Control in a Remote Area of South SudanPLOS Neglected Tropical Diseases, 2011
- Estimation of population coverage for antibiotic distribution for trachoma control: a comparison of methodsInternational Health, 2009
- Longitudinal evaluation of three azithromycin distribution strategies for treatment of trachoma in a sub-Saharan African country, MaliActa Tropica, 2007
- Projected benefits from integrating NTD programs in sub-Saharan AfricaTrends in Parasitology, 2006
- “Rapid-Impact Interventions”: How a Policy of Integrated Control for Africa's Neglected Tropical Diseases Could Benefit the PoorPLOS Medicine, 2005
- Achieving the Millennium Development GoalsThe Lancet, 2005
- Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children.2003